GSK2643943AMRTX1133pancreatic ductal adenocarcinoma (PDAC)
…-1 (anti-PD-1). In preclinical PDAC models, triple therapy with GSK2643943A, MRTX1133 and anti-PD-1 elicited a robust therapeutic response …
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: GSK2643943A ×
GSK2643943A
This drug is selected. Its supporting articles are shown below.